Roundtable on Genomics and Precision Health – November 15, 2023

On November 15, the National Academies’ Roundtable on Genomics and Precision Health will host a virtual event to highlight the work of the roundtable since the adoption of its strategic plan in 2020 and discuss what comes next. Speakers will provide their perspectives on the goals and key takeaways heard from workshop and event speakers. Public events since the strategic plan include:

  • Improving Diversity of the Genomics Workforce: A Workshop (2021)
  • Views & Voices: Reporting Genetics and Genomics (2022)
  • Realizing the Potential of Genomics across the Continuum of Precision Health Care: A Workshop (2022)
  • Next-Generation Screening – The Promise and Perils of DNA Sequencing of Newborns at Birth: A Workshop (2023)

REGISTER HERE

The event will be accessible via webinar and will begin on November 15 at 12 p.m. ET. Learn more on the event page.

Immediate Past President: Kathleen Swenson, MPH, MS (MA)

Immediate Past President: Kathleen Swenson, MPH, MS (MA)

Kathleen Swenson is an Assistant Professor of Medical Sciences & Education at the Boston University School of Medicine and Director of the Boston University Master’s Program in Genetic Counseling. She has 16 years of experience in genetic counseling in various clinical settings across many specialties (prenatal, pediatrics, neurology and cancer). Kathleen joined the NERGG Board of Directors in 2019.

Fabry in Females: Know When to Treat – December 6th 2022 at Noon

We would like to invite you to join us for a presentation and discussion about Fabry Disease.

Topic: Fabry in Females: Know When to Treat

Presented by:  Rob Hopkin, MD Cincinnati Children’s Hospital Medical Center

When: December 6th 12n ET

Where: Virtual Webinar

Please use this link to register:  https://healthstarcom.zoom.us/webinar/register/WN_fdjFjLbOTQGZpFed9EaxqA

Let me know if you need any assistance registering.  Once you have registered, you will receive a confirmation email from Sanofi Genzyme Virtual Events with a unique link for participation on December 6th.

We are looking forward to you participating.

Webinar discussion the Safety and Efficacy of Avalglucosidase alfa vs. Alglucosidase alfa in Patients with Late-onset Pompe disease – December 8th 2022 at 7pm

Sanofi Rare Disease has created an opportunity for healthcare professionals to come together to review and discuss the recent publication Safety and Efficacy of Avalglucosidase alfa vs. Alglucosidase alfa in Patients with Late-onset Pompe disease (COMET): A Phase 3, Randomized, Multicentre Trial.  Please see the attached invitation and link to register.  We are also including the information below.

When: Wednesday, December 8th 2022 @7pm
Location: Virtual
Presented by: David Kronn, MD
Westchester, NY
Registration via: Webinar Registration – Zoom

Once you have registered, you will receive an email from Sanofi Genzyme Virtual Events that contains the participant link for the day of the program.  You can add it to your calendar by following the prompts contained in that email.  Additionally, once we know of your intention to participate, we will send you an email with background information and the link to the journal article.  We are looking forward to your attendance and a robust discussion.

Please let us know if you have any difficulty registering.  We would be glad to assist.